Showing the single result
Composition: Each coated tablet contains: Ibandronic acid (as monosodium Ibandronate monohydrate) 150 mg.
Therapeutic Action: Osteoclast bone resorption inhibition.
Posology: One 150 mg tablet once a month on the same date each month.
Presentations: Containers containing 1, 2 and 3 tablets.